Revolution Medicines (RVMDW) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.61
-1.4
-1.19
-0.99

Details

Expected EPS
-1.421139
Actual EPS
-1.61
Surprise EPS
-0.19
Surprise Percent
+13.29%

Description

Revolution Medicines (RVMDW) has reported earnings of -1.61 per share for Q4 2025.

0 Comments

Share your thoughts